Stock Analysis: STERIS plc (STE)
Publication Date: September 22, 2024
Company Overview
STERIS plc (STE) is a leading player in the medical devices industry, headquartered in Mentor, Ireland. Founded in 1985, STERIS specializes in global infection prevention products and services, operating through three primary segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The company offers a comprehensive range of products, including cleaning chemistries and sterilization equipment, in addition to essential services such as equipment installation and maintenance. These offerings are designed to enhance patient safety and operational efficiency within hospitals and healthcare settings. With a total revenue of approximately $5.23 billion, STERIS is poised to leverage the growing opportunities within the healthcare sector, compounded by increasing healthcare expenditures and a focus on patient-centered care.
Market Performance and Analyst Outlook
With a current stock price of $236.98, STERIS plc is showing promising potential for growth. Analysts have established a high target price of $265.00, indicating significant room for upside and providing an attractive investment proposition. The average target mean price sits at $247.30, while the median price reflects a bullish outlook at $250.00. The range of expectation reflects a target low price of $230.00, highlighting potential volatility ahead. After reviewing the assessments of seven analysts, the consensus recommendation for STERIS is to “buy,” underlined by a recommendation mean score of 2.2.
Trading Dynamics and Investor Sentiment
Current market dynamics reveal that STERIS has 98,616,704 shares outstanding, with a relatively small percentage—approximately 2.39% or 1,826,343 shares—currently shorted. This indicates a stable investor interest in the stock, backed by a float of 98,246,930 shares. Additionally, STERIS’s stock is performing positively, trading slightly above its fifty-day moving average of $235.87, with the yearly trading range reflecting a high of $248.24 and a low of $195.47. The current trading price suggests strong investor confidence and continued bullish sentiment in the market, making STERIS plc a compelling candidate for those looking to invest in the thriving medical devices sector.
| Metric | Value |
|---|---|
| Market Cap | $23.4b |
| Total Debt | $2.5b |
| Total Cash | $198.3m |
| Shares Outstanding | 98.6m |
| Float Shares | 98.2m |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.